Macrogenics News

MacroGenics to Participate in Upcoming Investor Conference

MacroGenics to Participate in Upcoming Investor Conference ROCKVILLE, MD, June 11, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing,

MacrogenicsJun 11 00:00 ET

Shareholders in MacroGenics (NASDAQ:MGNX) Are in the Red If They Invested Three Years Ago

Yahoo FinanceJun 10 06:18 ET

Express News | Millennium Management LLC Reports 5.1% Passive Stake in MacroGenics Inc as of June 3 - SEC Filing

ReutersJun 4 16:54 ET

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results.SAIC reported a 9% revenue decline year over year in the fiscal first qua

BenzingaJun 3 13:56 ET

Demystifying Macrogenics: Insights From 14 Analyst Reviews

Analysts' ratings for Macrogenics (NASDAQ:MGNX) over the last quarter vary from bullish to bearish, as provided by 14 analysts.In the table below, you'll find a summary of their recent ratings, reveal

BenzingaMay 24 14:00 ET

Macrogenics Is Maintained at Buy by BTIG

Macrogenics Is Maintained at Buy by BTIG

Dow JonesMay 24 13:11 ET

Macrogenics Price Target Cut to $9.00/Share From $24.00 by BTIG

Macrogenics Price Target Cut to $9.00/Share From $24.00 by BTIG

Dow JonesMay 24 13:11 ET

Express News | BTIG Maintains Buy on Macrogenics, Lowers Price Target to $9

BenzingaMay 24 13:02 ET

B.Riley Financial Maintains Macrogenics(MGNX.US) With Buy Rating, Cuts Target Price to $18

B.Riley Financial analyst Mayank Mamtani maintains $Macrogenics(MGNX.US)$ with a buy rating, and adjusts the target price from $25 to $18.According to TipRanks data, the analyst has a success rate of

moomoo NewsMay 24 12:32 ET

Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Iovance Biotherapeutics (IOVA)

TipRanksMay 24 12:30 ET

Express News | MacroGenics Inc : Btig Cuts Target Price to $9 From $24

ReutersMay 24 00:40 ET

BTIG Maintains Macrogenics(MGNX.US) With Buy Rating, Cuts Target Price to $9

BTIG analyst Kaveri Pohlman maintains $Macrogenics(MGNX.US)$ with a buy rating, and adjusts the target price from $24 to $9.According to TipRanks data, the analyst has a success rate of 32.9% and a to

moomoo NewsMay 23 19:32 ET

Express News | MacroGenics Inc : Citigroup Cuts Target Price to $16 From $25

ReutersMay 20 06:44 ET

Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Bruker (BRKR)

TipRanksMay 18 11:31 ET

Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage...

PR NewswireMay 17 12:50 ET

FFIE, OGEN and CCLD Among Mid-day Movers

Seeking AlphaMay 13 13:30 ET

Stocks With More Than 10% Short Interest - Finviz Screener

Seeking AlphaMay 13 13:07 ET

Macrogenics Is Maintained at Neutral by HC Wainwright & Co.

Macrogenics Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesMay 13 12:35 ET

12 Health Care Stocks Moving In Monday's Intraday Session

GainersCareCloud (NASDAQ:CCLD) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million. Novavax (NASDAQ:NVAX) stock rose 42.17% to $12.6

BenzingaMay 13 12:31 ET

MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study Hagens Berman

Globe NewswireMay 13 12:30 ET